The author describes the scientific foundations and implications of the results of a randomized, controlled trial of Mim8, a new mimetic of factor VIIIa, to treat hemophilia A.
Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel demonstrated a highly statistically significant improvement versus paclitaxel alone in the key secondary endpoint of ...
Consuming a plant-based diet may help lower levels of a key marker of inflammation in the body, according to analysis of ...
Johnson & Johnson has initiated the PERSIGMA randomized controlled trial (RCT), one of the first randomized studies ...
Partial meniscectomy does not improve patient symptoms or function, reveals a 10-year follow-up of the FIDELITY, a ...
FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.
Olezarsen significantly lowers triglycerides and pancreatitis risk in severe hypertriglyceridemia, with a favorable short-term safety profile.
In adults with type 2 diabetes inadequately controlled on metformin alone, the combination of glimepiride, voglibose, and ...
A systematic review reveals adolescent cannabis use alters brain structure, elevates addiction risk, and impacts cognitive ...
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set ...
Introduction Suicidal ideation is common in young people and increases the risk of suicide. Effective interventions that are relevant and accessible to young people, so-called digital natives, are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results